ACTRN12621000153819
Recruiting
N/A
Creating an evidence base for clinical care: A randomised controlled study examining the efficacy of dietary therapy for the relief of gastrointestinal symptoms in endometriosis
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- endometriosis with gut symptoms
- Sponsor
- Monash University
- Enrollment
- 32
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women with diagnosed endometriosis experiencing gastrointestinal symptoms with a mean VAS symptom score \>30mm at baseline
Exclusion Criteria
- •Recent laparoscopic surgery in last 3 months, coeliac disease, other GI disease, e.g. Crohns disease, had a hysterectomy, or removal of ovaries, major bowel resection, known food allergy, malnutrition, active psychological illness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
The role of Rasayana therapy in management of chemotherapy induced side effectsCTRI/2021/05/033866Rasayu Cancer Clinic Pune
Completed
N/A
Implementation of a model of care for acute low back pain in emergency departmentsAcute low back painAcute exacerbation of chronic low back painMusculoskeletal - Other muscular and skeletal disordersACTRN12617001160325The University of Sydney4,824
Recruiting
N/A
Establishment of clinical research platform based on dementia cohortKCT0005516Samsung Medical Center300
Enrolling by Invitation
N/A
Effectiveness of an evidence-based care pathway to improve mobility and participation in older patients with vertigo and balance disorders in primary care (MobilE-PHY2): A multicentre cluster-randomised controlled trialR42H81R26R29.6F45.8Dizziness and giddinessDisorders of vestibular functionAbnormalities of gait and mobilityTendency to fall, not elsewhere classifiedOther somatoform disordersDRKS00028524Technische Hochschule Rosenheim, Fakultät für Angewandte Gesundheits- und Sozialwissenschaften120
Completed
N/A
A clinical study to assess the safety and effectiveness of different dosages of the same collagen peptide and different collagen peptide-containing test treatments in adult human subjectsHealth Condition 1: L709- Acne, unspecifiedHealth Condition 2: M170- Bilateral primary osteoarthritis of kneeHealth Condition 3: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereHealth Condition 4: M256- Stiffness of joint, not elsewhereclassifiedCTRI/2022/11/047149Collagen Lifesciences Private Limited264